Skilarence is an oral medication primarily used in the treatment of moderate to severe plaque psoriasis, a chronic autoimmune skin condition characterized by red, flaky, and scaly patches on the skin. The active ingredient in Skilarence is dimethyl fumarate, which works by modulating the immune system, although its exact mechanism of action in psoriasis is not fully understood. By targeting the immune response, Skilarence helps to reduce inflammation and the rapid skin cell growth associated with psoriasis, leading to an improvement in symptoms and the appearance of the skin. It is typically prescribed when topical treatments or phototherapy have not been effective or suitable for the patient. As with any medication, it is important for patients to discuss potential side effects and interactions with their healthcare provider before starting treatment with Skilarence.